Table 1. . Recruiting Phase I, II and III radiation trials of low-grade and anaplastic gliomas.
Study ID | Study title | Phase | Chemo | Year started |
---|---|---|---|---|
EORTC-26053, NCIC-CEC1, RTOG-0834, EUDRACT-2006–001533–17 MRC-BR14, NCT00626990 |
Radiation therapy with or without temozolomide in treating patients with anaplastic glioma (1p/19q not codeleted) | III | TMZ | 2009 |
NCCTG-N0577, NCIC-CEC2, EORTC-26081–22086, EUDRACT-2008–007295–14,NCT00887146 |
Radiation therapy or radiation therapy and temozolomide or temozolomide alone in treating patients with newly diagnosed anaplastic glioma (1p/19q codeleted) | III | TMZ, PCV | 2009 |
ECOG-E3F05, NCT00978458 |
Radiation therapy with or without temozolomide in treating patients with low-grade glioma | III | TMZ | 2009 |
NCT01358058 | Proton radiation therapy for low-grade gliomas | II | N/A | 2011 |
NCT01024907 | Proton beam radiation therapy in treating patients with low-grade gliomas | I–II | N/A | 2013 |